Search for: [Abstract = "Clostridioides difficile is a common bacteria in humans, but pathogenic strains may contribute to the development of so\-called antibiotic diarrhea in which the main factor of exposure to infection is taking antibiotics. In healthy people, the main protection against CDI \(C. difficile infection\) is the normal mucosa along with the microbiota that can be disrupted by antibiotics. Other significant risk factors for CDI occurrence are age, hospitalization, and previous operations. In 2016, the average incidence of CDI in the EU was 2.38 \/ 10,000 patient\-days \(pds\), and in Poland as much as 6.2 \/ 10,000 pds. As CDI infections are closely related to antibiotic therapy, it is suggested that CDI may be considered as biomarker of the appropriate antibiotic use. The aim of the study was to evaluate the local, national and European epidemiology of C. difficile in the context of the use of antibiotics in prophylaxis and treatment. Surveillance of CDI covered surgical patients of treatment wards at the St. Łukasz in Tarnów. In addition, data was obtained from the Polish National Health Fund \(NHF\) and ECDC databases on the presence of CDI and the prescription or use of antibiotics. Data concerning\: consumption \|of antibiotics, incidence of CDI, length of hospitalization, and patient characteristics were analyzed. In the Healthcare\-Associated CDI \(HA\-CDI\) local study, the incidence of infect"]

Number of results: 1